Octave narrows Q3 loss as distribution growth offsets pricing pressure

By Tom Whitfield

Octave Specialty Group (NYSE:OSG) reported a $13.8 million net loss to shareholders in the third quarter of 2026, or $0.31 per share, compared with a $31.7 million loss from continuing operations, or $0.65 per share, a year earlier.

What changed in the third quarter?

• Adjusted EBITDA to shareholders reached $3.3 million, versus a $2.9 million loss a year earlier.
• The adjusted net loss narrowed to $1.3 million, or $0.03 per share, from $10 million, or $0.21 per share.

CFO David Trick attributed the improvement to organic growth across the business, the October 2025 acquisition of ArmadaCare, lower corporate expenses and reduced interest expense. Adjusted corporate expenses fell to $7.3 million from $9.5 million.

The figures show a smaller reported loss, not positive net income. Octave did not formally update its 2026 guidance.

Trick said Octave remains “on track for its first year of positive adjusted net income per share since launching its property and casualty strategy in 2021.” That claim depends on distribution earnings and Everspan meeting full-year targets; the third-quarter consolidated adjusted net result remained negative.

Takeaway: Better adjusted earnings narrowed the loss, but positive net income still depends on management meeting its operating targets.

Can distribution carry the outlook?

Insurance distribution revenue climbed 35% to $58 million, including 23% organic growth. President and Chief Executive Officer Claude LeBlanc attributed the increase to organic growth and ArmadaCare.

Segment adjusted EBITDA to shareholders rose nearly 40% to $8.3 million, lifting the adjusted EBITDA margin to 14.2% from 13.9%. The segment still lost $4.2 million, compared with $5.4 million a year earlier.

Year-to-date organic growth was just over 35%, against full-year organic-growth guidance of more than 25%. Trick said Octave expects to exceed $45 million of full-year insurance distribution adjusted EBITDA and anticipates double-digit organic growth in the fourth quarter. These are management expectations rather than revised formal guidance.

ArmadaCare enters the organic-growth calculation in November, after the acquisition anniversary. Trick said the business is seasonal and likely to have a smaller fourth-quarter effect, but he expects a “rather significant favorable impact” on organic growth in the first quarter of 2027. That comparison will test whether the distribution run rate can survive a less favorable seasonal contribution.

LeBlanc said accident and health accounts for about one-third of Octave’s portfolio and diversifies the company from the property and casualty pricing cycle. Double-digit rate increases in accident and health, driven by rising health-care costs, support growth, although management supplied no separate revenue target for the line.

Takeaway: Distribution provides the clearest earnings growth, but the fourth quarter and 2027 comparison remain the checks.

What improved at Everspan?

Octave’s specialty property and casualty business, Everspan, generated $2.2 million of adjusted EBITDA to shareholders, compared with less than $0.1 million a year earlier. Gross premiums written increased 2% to $99 million. Net premiums written and net premiums earned each reached $26 million, up 44% and 52%, respectively.

The combined ratio improved to 100.6% from 112.9%, driven by a lower loss ratio. The expense ratio increased, however, because a growing mix of high-retention programs raised acquisition costs and general and administrative expenses rose. Everspan improved its combined ratio, but the ratio remained above 100% and the expense burden increased.

Trick said full-year gross premiums written could fall slightly below $410 million guidance because of business-mix changes and the timing of new program launches. He nevertheless said Everspan was positioned to meet or exceed $6 million of full-year adjusted EBITDA guidance. That expectation depends on mix and launch timing, not simply higher premium volume.

After the quarter ended, Everspan agreed to sell its Providence Washington Insurance Company subsidiary. Management expects the transaction to close by early 2027, and Trick projects a consolidated net gain of nearly $4 million and an approximately $11 million increase in Everspan’s tangible book value when it closes. Those figures remain subject to completion.

Takeaway: Everspan’s ratios improved, but premium guidance is already under pressure.

What does pricing and technology reveal?

LeBlanc said abundant capacity has made the property and casualty market more competitive, with global commercial rates declining for a ninth consecutive quarter. Property rates fell roughly 10% in the third quarter, although some casualty and specialty classes continued to post increases. Octave’s pricing backdrop remains uneven rather than uniformly weak.

Despite that environment, LeBlanc said Octave’s 2027 capacity was largely lined up and that the company expects to be oversubscribed. He also said all managing general agencies operate on their target technology platforms and that an AI-driven submission-intake rollout across U.S. agencies is largely complete. The call supplied no figures for capacity, oversubscription or the completed deployment.

LeBlanc reiterated a target of $80 million in consolidated adjusted EBITDA to shareholders for 2028. Octave develops, underwrites and manages specialty insurance products across selected lines for complex, hard-to-place risks. Its platforms serve customers and distribution partners seeking coverage outside standard commercial markets, using specialized expertise, tailored policy structures and disciplined risk selection.

Takeaway: Octave has stronger distribution numbers, but neither soft pricing nor the 2028 target is settled.